Incyte (INCY) FCF Margin (2010 - 2026)
Incyte's (INCY) quarterly FCF Margin came in at 29.58% in Q2 2026, up 2747.0% YoY from 1.04% in Q2 2025, and up 4.83% on a QoQ basis from 28.22% in Q1 2026.
Powered by 
Analysis
Incyte (INCY) FCF Margin (2010 - 2026) Analysis & Trends
Incyte (INCY) has 17 years of FCF Margin data on file, last reported at 29.58% in Q2 2026.
- Quarterly FCF Margin rose 2747.0% year-over-year to 29.58% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 33.0% (up 1210.0% YoY) and the FY2025 annual result came in at 26.35%, up 2048.0% from the prior year.
- FCF Margin climbed to 29.58% in Q2 2026, from 28.22% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 39.87% in Q3 2025 to a low of 60.33% in Q2 2024.
- A 5-year average of 18.47% and a median of 26.98% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin plunged 9167 bps — and 2025, when it jumped 6244 bps.
- Tracing INCY's FCF Margin over 5 years: stood at 28.31% in 2022, then plunged by 49 bps to 14.35% in 2023, then jumped by 115 bps to 30.87% in 2024, then grew by 12 bps to 34.6% in 2025, then decreased by 15 bps to 29.58% in 2026.
- The last three FCF Margin figures came in at 29.58% (Q2 2026), 28.22% (Q1 2026), and 34.6% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 29.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.58% |
| Mar 31, 2026 | 28.22% |
| Dec 31, 2025 | 34.60% |
| Sep 30, 2025 | 39.87% |
| Jun 30, 2025 | 2.11% |
| Mar 31, 2025 | 24.97% |
| Dec 31, 2024 | 30.87% |
| Sep 30, 2024 | 26.86% |
| Jun 30, 2024 | -60.33% |
| Mar 31, 2024 | 23.76% |
| Dec 31, 2023 | 14.35% |
| Sep 30, 2023 | 14.89% |
| Jun 30, 2023 | 31.34% |
| Mar 31, 2023 | -14.53% |
| Dec 31, 2022 | 28.31% |
| Sep 30, 2022 | 32.62% |
| Jun 30, 2022 | 17.82% |
| Mar 31, 2022 | 27.10% |
| Dec 31, 2021 | 9.37% |
| Sep 30, 2021 | 27.42% |